Drug-Drug Interaction of Cladribine and Pantoprazole in Multiple Sclerosis Subjects
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the influence of pantoprazole on the pharmacokinetic
profile of cladribine, especially in terms of extent of absorption of cladribine since
pH-modifying drug may potentially affect the stability of cladribine and thereby its
bioavailability